Improving Resection Rates Among African Americans With NSCLC
연구 개요
상세 설명
The burden to participants will be minimized to enhance retention. Patients in the usual care arm receive the current "gold standard" of treatment. The patients in the intervention arm are assigned to a PN, who helps to reduce the barriers to care that could negatively impact the patients' receipt of LDTCI. The telephone-administered survey is administered to all study participants at baseline and at 3-, 6-, and 12-months post-enrollment. It takes approximately 30-40 minutes to administer. The telephone mode of survey administration was chosen to reduce the number of visits that would be required by each patient. Interviews are scheduled at the convenience of the study participants. To further reduce burden to the study participants, the interviewers offer breaks during the interview process. Patients in both arms undergo standard therapy visits. Patients in the navigation arm receive standard therapy visits plus the navigation intervention. Outside of the standard therapy visits, no additional clinic visits are required of the study participants.
Once informed consent has been obtained and the informed consent document is received, the SSC/PN will communicate to the MUSC HCC study staff the participant's contact information and that the participant is ready for baseline survey administration. All the study surveys will be administered by trained MUSC HCC study staff via telephone. A survey answer guide will be provided to the participant either in-person or via mail prior to administration of the baseline survey.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Delaware
-
Lewes, Delaware, 미국, 19958
- Beebe Healthcare Tunnell Cancer Center
-
-
Georgia
-
Savannah, Georgia, 미국, 31405
- Saint Joseph's/Candler Hospital
-
-
Illinois
-
Chicago, Illinois, 미국, 60612
- Stroger Hospital of Cook County
-
-
Louisiana
-
New Orleans, Louisiana, 미국, 70121
- Ochsner NCORP
-
-
Michigan
-
Royal Oak, Michigan, 미국, 48073
- Beaumont Hospital - Royal Oak
-
-
Minnesota
-
Saint Louis Park, Minnesota, 미국, 55426
- Metro-Minnesota NCORP
-
-
Nevada
-
Las Vegas, Nevada, 미국, 89106
- Nevada Cancer Research Foundation
-
-
North Carolina
-
Winston-Salem, North Carolina, 미국, 27127
- Wake Forest University Health Sciences
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, 미국, 19111
- Fox Chase
-
-
Virginia
-
Richmond, Virginia, 미국, 23298
- Virginia Commonwealth University
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- AA race
- Clinically suspicious or biopsy-proven, early stage NSCLC, and
- Ages 21 years and older
Exclusion Criteria:
- Previous history of lung cancer
- Spread of newly diagnosed probably/proven lung cancer to other part of the body
- Diagnosis of synchronous cancer other than non-melanoma skin cancer or lung cancer, and
- Receipt of surgical resection or radiosurgery for lung cancer since diagnosis with probable/proven lung cancer
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: Usual Care Arm
Participants who are assigned to the usual care arm may receive the following services: complete staging work-up (CT/PET scan and possible mediastinoscopy), surgical consultation with a general or cardiothoracic surgeon, cardiac clearance and/or pulmonary function testing (if deemed necessary by the evaluating surgeon), surgical resection (wedge resection, lobectomy, pneumonectomy, or radiosurgery, as indicated by the size and location of the tumor), and adjuvant therapy (radiotherapy and/or chemotherapy, as determined by the intraoperative findings and pathology results).
|
Usual care includes: complete staging work-up (CT/PET scan and possible mediastinoscopy), surgical consultation with a general or cardiothoracic surgeon, cardiac clearance and/or pulmonary function testing (if deemed necessary by the evaluating surgeon), surgical resection (wedge resection, lobectomy, pneumonectomy, or radiosurgery, as indicated by the size and location of the tumor), and adjuvant therapy (radiotherapy and/or chemotherapy, as determined by the intraoperative findings and pathology results).
|
|
실험적: Intervention Arm
The PN will provide each patient with a copy of the NCI's "What You Need to Know About Lung Cancer" booklet and encourage them to re-contact his/her primary care physician (or the physician who diagnosed their probable/proven NSCLC) to discuss treatment options. The PNs will provide patients with their contact information and brief patients on their role. The PNs will navigate study participants for up to 4 months (16 weeks, 112 days) after NSCLC diagnosis, until the patient is deemed ineligible for LDTCI (i.e., lung resection or SBRT) by their physician(s), until receipt of LDTCI, or death (whichever comes first). During the EPDPN intervention period, PNs will contact each intervention group participant by telephone (or in-person) on weekly basis (at minimum). |
The proposed Intervention (EPDPN) will be administered by the PNs at the intervention sites on an outpatient basis.
Several defining, fundamental characteristics of the PNs will ensure consistency of the intervention delivery across the various study sites.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Receipt of LDTCI
기간: 12 Months Post-Enrollment
|
Receipt of lung-directed therapy with curative intent (LDTCI), Inquiry at time of follow-up survey, confirmed by medical record review
|
12 Months Post-Enrollment
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Receipt of Surgical and/or Radiation Oncology Consultation Confirmed by Medical Record Review
기간: Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
• Receipt of surgical and/or radiation oncology consultation (defined as outpatient or inpatient consultation with a general or cardiothoracic surgeon and/or radiation oncologist to discuss LDTCI for NSCLC within 4 months post-diagnosis of probable/proven, early stage NSCLC).
|
Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
|
Time to LDTCI (For Pts. Who Received LDTCI Only) Confirmed by Medical Record Review
기간: Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
Time to LDTCI (For Pts.
Who Received LDTCI Only).
Inquiry at Time of Follow-Up Survey, Confirmed by Medical Record Review.
Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
|
Satisfaction with Care Received, Patient Satisfaction(REF) (28 items)
기간: 6 Months Post-Enrollment
|
Satisfaction with Care Received, Patient Satisfaction(REF) (28 items).
6 Months Post-Enrollment
|
6 Months Post-Enrollment
|
|
Time of Death, Follow-up Survey, Confirmed by Medical Record Review
기간: Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
Time of Death.
Inquiry at Time of Follow-Up Survey, Confirmed by Medical Record Review , inquiry of cancer registries at study sites, and inquiry of Social Security Death Index.
Baseline, 3, 6, 9, and 12 Months Post-Enrollment.
|
Baseline, 3, 6, 9, and 12 Months Post-Enrollment
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Kathryn E Weaver, PhD, Wake Forest Universith Health Sciences
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .